Chronic hepatitis C virus;Hépatite chronique virale C

Revue Francaise des Laboratoires

Volumn 2003, Issue 358, 2003, Pages 25-30

  Buffet, Catherine ^a  

^a BICÊTRE HOSPITAL   (France)

Author keywords

Chronic hepatitis C; Cirrhosis; Diagnosis; HCV; Hepatitis fibrosis; Risk factors; Treatment

Indexed keywords

ALCOHOL; HEPATITIS C ANTIBODY; PEGINTERFERON; RIBAVIRIN; VIRUS RNA;

AGE DISTRIBUTION; ALCOHOL CONSUMPTION; ASSOCIATION; BLOOD TRANSFUSION; CHRONIC HEPATITIS; CLINICAL FEATURE; CONTAMINATION; DIAGNOSTIC PROCEDURE; DISEASE COURSE; DRUG USE; ENZYME IMMUNOASSAY; EPIDEMIOLOGICAL DATA; EXPOSURE; GENOTYPE; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; IMMUNE DEFICIENCY; IMMUNE RESPONSE; INJECTION; LIVER BIOPSY; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; LIVER FIBROSIS; LIVER TRANSPLANTATION; NONHUMAN; OBESITY; PARENT; PATHOGENESIS; POLYMERASE CHAIN REACTION; REVIEW; RISK FACTOR; RNA VIRUS; SEROLOGY; TURNOVER TIME; VIRAL GENETICS; VIROLOGY; VIRUS TRANSMISSION;

EID: 0842308959     PISSN: 03389898     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0338-9898(03)90043-6     Document Type: Review

References (13)

1. Alric L, Di-Martino V., Selves J., Cacoub P., Charlotte F., Reynaud D., Piette J.C., Peron J.M., Vinel J.P., Durand D., Izopet J., Poynard T., Duffaut M., Rostaing L., Long-term impact of renal transplantation on liver fibrosis during hepatitis C virus infection, Gastroenterology 123 (2002) 1494-149 9.
2. Conférence de consensus, Traitement de l'hépatite C, Gastroenterol. Clin. Biol. 26 (2002) B5-B320.
3. Tilman Gerlach J., Helmut M., Diepolder H.M., Zachoval R., Gruener N.H., Jung M.C., Ulsenheimer A., Schraut W.W., Schirren C.A., Waechtler M., Backmund M., Pape G.R., Acute hepatitis C : high rate of both spontaneous and treatment-induced viral clearance, Gastroenterology 125 (2003) 80-88.
4. Ghany M.G., Kleiner D.E., Alter H., Doo E., Khokar F., Promrat K., Herion D., Park Y., Liang T.J., Hoofnagle J.H., Progression of fibrosis in chronic hepatitis C, Gastroenterology 124 (2003) 97-104.
5. Imbert-Bismuth F, Ratziu V., Pieroni L., Charlotte F., Benhamou Y., Poynard T., Biochemical markers of liver fibrosis in patients with hepatitis C virus infection : a prospective study, Lancet 357 (2001) 1069-1075.
6. Keeffe E.B., Controversies in viral hepatitis : is liver biopsy always necessary before treating chronic hepatitis B or C ? No. American association for the study of liver diseases. Post graduate course 2003. John B. Hynes. Convention Center Boston, Massachusetts, pp.123-128.
7. Kumar D., Farrell G.C., Fung C., George J., Hepatitis C virus genotype 3 is cytopathic to hepatocytes : reversal of hepatic steatosis after sustained therapeutic response, Hepatology 36 (2002) 1266-1272.
8. Monto A., Alonzo J., Watson J.J., Grunfeld C., Wright T.L., Steatosis in chronic hepatitis C : relative contributions of obesity, diabetes mellitus and alcohol, Hepatology 36 (2002) 729-736.
9. Neumann A.U., Lam N.P., Dahari H., Gretch D.R., Wiley T.E., Layden T.J., Perelson A.S., Hepatitis C viral dynamics in vivo and the antiviral efficacy of interferon-α therapy, Science 282 (1998) 103-107.
10. Seeff L.B., Hoofnagle J.H., National institutes of health consensus development conference : management of hepatitis C : 2002, Hepatology 36 (2002) S1-S252.
11. Shiffman M.L., Controversies in viral hepatitis : is liver biopsy always necessary before treating chronic hepatitis B or C ? Yes. American assocation for the study of liver diseases. Post graduate course 2003, John B. Hynes, Convention center Boston, Massachusetts, pp.119-122.
12. Yeung L.T.F., King S.M., Roberts E.A., Mother-to-infant transmission of hepatitis C virus, Hepatology 34 (2001) 223-228.
13. Zhang T., Li Y., Lai J.P., Douglas S.D., Metzger D.S., O'Brien C.P., Ho W.Z., Alcohol potentiates hepatitis C virus replicon expression, Hepatology 38 (2003) 57-65.